> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Five OPDP Research Studies Awaiting Publication
- URL: https://www.fdaweb.com/five-opdp-research-studies-awaiting-publication/
- Published: 2019-09-17T12:00:00.000Z
- Updated: 2026-09-15T01:50:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145023

The Coalition for Healthcare Communication says five CDER Office of Prescription Drug Promotion research studies are completed and awaiting peer review and publication. Four of the studies look at aspects of direct-to-consumer (DTC) advertising.

Coalition executive director **Jon Bigelow** [says](http://cohealthcom.org/2019/09/16/opdp-dtc-research-studies-await-peer-review-are-poised-for-publication/?ref=fdaweb.com) the studies “will make an important contribution to the body of information about DTC and how best to design it for recall and comprehension. They will provide useful information on the impact of new trends in how messages are accessed (such as viewership on tablets and use of animation and superimposed text) and on the targeting of messages to adolescents, as well as providing further data about patient attitudes toward DTC.”

The five studies cover animation in DTC promotion, experimental study of DTC directed at adolescents, general population survey on prescription drug promotion, risk and benefit perception scale development, and superimposed text in DTC promotion.